NEW ORLEANS — For people with type 2 diabetes (T2D) inadequately controlled on submaximal dulaglutide (Trulicity) doses, switching to tirzepatide (Mounjaro) produces significantly greater A1c and weight lowering than does escalating dulaglutide treatment. “Often, when we are with a patient who is not meeting treatment goals...
The Center For Mind & Esteem Development, Inc. A Course In Personal & Professional Development LoveNow360 For Self, Community & World Engagement & Empowerment Marvin Mack, Founder & Creative Director lovenow360.net
410-971-6235
personaldevelopment@me.com
Copyright © 2023 lovenow360 for Self, Community & World Engagement & Empowerment
The Center For Mind & Esteem Development, Inc.. All Rights Reserved
